Literature DB >> 26254607

A chromatography/tandem mass spectrometry method for the simultaneous profiling of ten endogenous steroids, including progesterone, adrenal precursors, androgens and estrogens, using low serum volume.

Patrick Caron1, Véronique Turcotte1, Chantal Guillemette2.   

Abstract

Measurement of a large set of sex steroids in clinical epidemiology and laboratory research with reliable methods providing low quantification limits and using a limited volume of blood sample represents a significant challenge. We report a new validated gas chromatography selected reaction monitoring - tandem mass spectrometry assay (GC-MS/MS) for the simultaneous quantification of ten endogenous steroids including progesterone (PROG), dehydroepiandrosterone (DHEA), androstenediol (5-diol), androstenedione (4-dione), testosterone (T), dihydrotestosterone (DHT), androsterone (ADT), 5alpha-androstan-3beta-17beta-diol (3β-diol), estrone (E1) and estradiol (E2). After addition of stable isotope internal standards, the approach involved the combination of liquid-liquid extraction, derivatization and solid-phase extraction for injection into the GC system and multiple reaction monitoring (MRM). The method presents high reproducibility for all analytical parameters in 250 μl serum samples. The lower limit of quantification (LLOQ) were of 100 pg/ml for DHEA, 50 pg/ml for PROG, 5-diol, 4-dione and ADT, 30 pg/ml for T, 10 pg/ml for 3β-diol and DHT, 5 pg/ml for E1, and 1 pg/ml for E2. The applicability of the validated method to determine the concentrations of these 10 steroids was successfully tested on serum from men (n=15), premenopausal (n=10) and postmenopausal women (n=20), and is currently used for larger cancer-related epidemiology studies. One of the most considerable advantages over existing methods is the simultaneous determination of ten steroids in a limited volume of serum that will help conserve important clinical samples from existing biobanks.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgens; Clinical samples; Estradiol; GC–MS/MS; Mass spectrometry; Postmenopausal; Steroids

Mesh:

Substances:

Year:  2015        PMID: 26254607     DOI: 10.1016/j.steroids.2015.07.009

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  10 in total

1.  Sex steroid hormones in relation to Barrett's esophagus: an analysis of the FINBAR Study.

Authors:  M B Cook; S Wood; P L Hyland; P Caron; J Drahos; R T Falk; R M Pfeiffer; S M Dawsey; C C Abnet; P R Taylor; C Guillemette; L J Murray; L A Anderson
Journal:  Andrology       Date:  2017-02-27       Impact factor: 3.842

2.  Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.

Authors:  Jessica L Petrick; Paula L Hyland; Patrick Caron; Roni T Falk; Ruth M Pfeiffer; Sanford M Dawsey; Christian C Abnet; Philip R Taylor; Stephanie J Weinstein; Demetrius Albanes; Neal D Freedman; Susan M Gapstur; Gary Bradwin; Chantal Guillemette; Peter T Campbell; Michael B Cook
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

3.  Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Liver Cancer Among Postmenopausal Women.

Authors:  Jessica L Petrick; Andrea A Florio; Xuehong Zhang; Anne Zeleniuch-Jacquotte; Jean Wactawski-Wende; Stephen K Van Den Eeden; Frank Z Stanczyk; Tracey G Simon; Rashmi Sinha; Howard D Sesso; Catherine Schairer; Lynn Rosenberg; Thomas E Rohan; Mark P Purdue; Julie R Palmer; Martha S Linet; Linda M Liao; I-Min Lee; Jill Koshiol; Cari M Kitahara; Victoria A Kirsh; Jonathan N Hofmann; Chantal Guillemette; Barry I Graubard; Edward Giovannucci; J Michael Gaziano; Susan M Gapster; Neal D Freedman; Lawrence S Engel; Dawn Q Chong; Yu Chen; Andrew T Chan; Patrick Caron; Julie E Buring; Gary Bradwin; Laura E Beane Freeman; Peter T Campbell; Katherine A McGlynn
Journal:  Hepatology       Date:  2020-08       Impact factor: 17.298

4.  Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients.

Authors:  Eric P Allain; Karin Venzl; Patrick Caron; Véronique Turcotte; David Simonyan; Michaela Gruber; Trang Le; Eric Lévesque; Chantal Guillemette; Katrina Vanura
Journal:  Ann Hematol       Date:  2018-05-21       Impact factor: 3.673

5.  Profiling of Steroid Metabolic Pathways in Human Plasma by GC-MS/MS Combined with Microwave-Assisted Derivatization for Diagnosis of Gastric Disorders.

Authors:  Wonwoong Lee; Hyunjung Lee; You Lee Kim; Yong Chan Lee; Bong Chul Chung; Jongki Hong
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

6.  Quantification of 17 Endogenous and Exogenous Steroidal Hormones in Equine and Bovine Blood for Doping Control with UHPLC-MS/MS.

Authors:  Giovanni Caprioli; Michele Genangeli; Ahmed M Mustafa; Riccardo Petrelli; Massimo Ricciutelli; Gianni Sagratini; Stefano Sartori; Fulvio Laus; Sauro Vittori; Manuela Cortese
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-21

Review 7.  Breast Cancer: Targeting of Steroid Hormones in Cancerogenesis and Diagnostics.

Authors:  Marcela Valko-Rokytovská; Peter Očenáš; Aneta Salayová; Zuzana Kostecká
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

8.  Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study.

Authors:  Jessica L Petrick; Roni T Falk; Paula L Hyland; Patrick Caron; Ruth M Pfeiffer; Shannon N Wood; Sanford M Dawsey; Christian C Abnet; Philip R Taylor; Chantal Guillemette; Liam J Murray; Lesley A Anderson; Michael B Cook
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

9.  Systemic estradiol levels with low-dose vaginal estrogens.

Authors:  Richard J Santen; Sebastian Mirkin; Brian Bernick; Ginger D Constantine
Journal:  Menopause       Date:  2020-03       Impact factor: 3.310

10.  Follicle-stimulating hormone (FSH) levels prior to prostatectomy are not related to long-term oncologic or cardiovascular outcomes for men with prostate cancer.

Authors:  Kassim Kourbanhoussen; France-Hélène Joncas; Christopher J D Wallis; Hélène Hovington; François Dagenais; Yves Fradet; Chantal Guillemette; Louis Lacombe; Paul Toren
Journal:  Asian J Androl       Date:  2022 Jan-Feb       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.